Halim, M A <br/><br/>
Early sirolimus therapy in renal transplant recipients at high risk: is it justified?  [electronic resource] 

 -  Transplantation proceedings  Sep 2009 
 - 2784-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-2623 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2009.07.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Biopsy<br/>Cadaver<br/>Female<br/>Graft Rejection--drug therapy<br/>Graft Survival--drug effects<br/>Histocompatibility Testing<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Kidney Transplantation--immunology<br/>Living Donors<br/>Male<br/>Middle Aged<br/>Patient Selection<br/>Proteinuria--epidemiology<br/>Risk Factors<br/>Sirolimus--administration & dosage<br/>Tissue Donors--statistics & numerical data<br/>Treatment Failure<br/>Treatment Outcome